Aptar Pharma and Medtech firms to Develop Novel Auto-injector
Aptar Pharma, a division of AptarGroup, has entered into an exclusive development and license agreement with BD (Becton, Dickinson and Company), a leading medtech firm, to collaboratively create an innovative auto-injector.
In the development of this auto-injector, Aptar Pharma will leverage its two-step auto-injector technology along with prefillable syringes provided by BD.
Auto-injectors are specifically designed to enable patients to self-administer injections safely and conveniently outside of medical settings.
The new platform design focuses on user-friendliness, ergonomic shape, enhanced feedback indicators, and the capability to accommodate viscous drug formulations.
The auto-injector technology has been tailored exclusively for BD Neopak™ 1mL long glass prefillable syringes or the BD Hypak™ for Biotech 1 mL long glass prefillable syringes, ensuring optimal system durability and performance.
Aptar Pharma will combine its auto-injector technology platform with BD's expertise in prefillable syringes, combining self-injection technologies with Aptar Pharma's innovation and quality-by-design proficiency.
